Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of topical MOB015B in distal subungual onychomycosis
2012-003722-24Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Terclara in onychomycosis, sponsored by Moberg Pharma AB. Primary endpoint: Mycological cure of target nail (culture + direct microscopy). Started Sep 2012; status: completed.
02
Drugs
Terclara
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2012-003722-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003722-24.